Tropic Biosciences
UK agricultural biotech company using CRISPR gene editing and proprietary GEiGS technology to develop disease-resistant, climate-resilient tropical crops including bananas, coffee, and rice.
Overview
Tropic Biosciences is a Norwich-based agricultural biotechnology company applying cutting-edge genetic innovation to tropical agriculture. Using CRISPR gene editing combined with its proprietary GEiGS (Gene Editing induced Gene Silencing) platform, Tropic develops crop varieties with improved disease resistance, reduced pesticide dependency, and enhanced climate resilience. The company focuses on staple tropical crops — bananas, coffee, and rice — that are critical to global food security but increasingly threatened by climate change and disease. Tropic's banana program addresses Panama disease (Tropical Race 4), a devastating fungal pathogen that threatens global banana production. The company's gene-edited varieties aim to provide durable resistance without relying on chemical treatments, enabling brighter futures for tropical growers worldwide.
Funding History
Tropic Biosciences secures €91.3M Series C to scale gene-edited bananas and climate-resilient crops globally.
Frequently Asked Questions
- How much funding does AI Funding track for Tropic Biosciences?
- AI Funding tracks $105M for Tropic Biosciences across 1 funding round in this database.
- What does Tropic Biosciences do?
- Tropic Biosciences is a Norwich-based agricultural biotechnology company applying cutting-edge genetic innovation to tropical agriculture. Using CRISPR gene editing combined with its proprietary GEiGS (Gene Editing induced Gene Silencing) platform, Tropic develops crop varieties with improved disease resistance, reduced pesticide dependency, and enhanced climate resilience. The company focuses on staple tropical crops — bananas, coffee, and rice — that are critical to global food security but increasingly threatened by climate change and disease. Tropic's banana program addresses Panama disease (Tropical Race 4), a devastating fungal pathogen that threatens global banana production. The company's gene-edited varieties aim to provide durable resistance without relying on chemical treatments, enabling brighter futures for tropical growers worldwide.
- Where is Tropic Biosciences headquartered?
- Tropic Biosciences is headquartered in Norwich, United Kingdom.
Related Insights
Compare the leading AI-focused VC firms: Andreessen Horowitz, Sequoia Capital, Thrive Capital, and 7 more. Analysis of 150+ AI deals, investment strategies, sector focus, and portfolio performance.
Track 395+ AI funding rounds—investors, valuations, and deal sizes from pre-seed to IPO. Updated daily so you never miss a round.
An in-depth look at how AI-focused venture capital operates — from fund structure and deal sourcing to due diligence, portfolio management, and exit strategies in the AI era.